Xiaoling Yang

Xiaoling Yang is currently a Biomarker Program Manager III at AbbVie, specializing in Precision Medicine. They have previously held positions at Novartis as a Translational Project Manager and Scientist, where they managed clinical trials and conducted extensive biomarker research in oncology. Xiaoling also worked as a Development Associate at Quidel, contributing to the development of in vitro diagnostic assays. Earlier in their career, they served as a Teaching and Research Assistant at Clark University, focusing on genetic mutations and biological activity screening. Xiaoling holds a Master of Arts in Biology from Clark University, a Bachelor of Science in Biotechnology from Northwest A & F University, and a Master of Science in Software Development from Boston University.